glp-1 drugs pcos Ozempic (Semaglutide) for PMOS/PCOS: Pelvic Health Guide Can Ozempic Help with PCOS?

1 Introduction The success and ever increasing interest in incretin-based therapies and drugs especially sitagliptin, vildagliptin and exenatide depict their immense importance in improving patient outcomes in T2DM (Nasr and Sadek, 2022)

Hwang YJ, Kim N, Yun CY, Yoon H, Shin CM, Park YS, et al

In real-world settings, access to GLP-1 RAs is shaped by practical considerations, such as drug availability, insurance coverage, and formulary decisions that can directly impact the treatments millions of patients receive

A systematic review and meta-analysis published in eClinicalMedicine found that discontinuing GLP-1 receptor agonist treatment led to an average weight regain of 5.63 kg and 5.81% of body weight across all patients studied

The formulary will show which tier each medication falls into and whether prior authorization is required

Sarwer DB, Hanson AJ, Voeller J, Steffen K